Neurologic Injury in Patients With COVID-19 Who Receive VV-ECMO Therapy: A Cohort Study (Letter)

Kannapadi, Nivedha V; Jami, Meghana; Premraj, Lavienraj; Etchill, Eric W; Giuliano, Katherine; Bush, Errol L; Kim, Bo Soo; Seal, Stella; Whitman, Glenn; Cho, Sung-Min

doi:10.1053/j.jvca.2021.05.017

Author(s)

Kannapadi, Nivedha V

Jami, Meghana

Premraj, Lavienraj

Etchill, Eric W

Giuliano, Katherine

Bush, Errol L

Kim, Bo Soo

Seal, Stella

Whitman, Glenn

Cho, Sung-Min

Griffith University Author(s)

Premraj, Lavienraj

Year published

2021

Metadata

Show full item record

Abstract

To the Editor: THROMBOTIC AND BLEEDING events have been implicated in the progression of coronavirus disease 2019 (COVID-19).1,2 This dysregulation of coagulation has been associated with poor prognoses.3,4 Neurologic sequelae, such as ischemic stroke and intracranial hemorrhage (ICH), have been reported in patients with COVID-19 at rates of 0.9%-to-2.3% and 0.9%, respectively.5,6,7,8 Limited data exist on neurologic events in patients with COVID-19 in the intensive care unit who require extracorporeal membrane oxygenation (ECMO) due to severe acute respiratory distress syndrome (ARDS).To the Editor: THROMBOTIC AND BLEEDING events have been implicated in the progression of coronavirus disease 2019 (COVID-19).1,2 This dysregulation of coagulation has been associated with poor prognoses.3,4 Neurologic sequelae, such as ischemic stroke and intracranial hemorrhage (ICH), have been reported in patients with COVID-19 at rates of 0.9%-to-2.3% and 0.9%, respectively.5,6,7,8 Limited data exist on neurologic events in patients with COVID-19 in the intensive care unit who require extracorporeal membrane oxygenation (ECMO) due to severe acute respiratory distress syndrome (ARDS).
View less >